Quantcast

Nobel Media and AstraZeneca Bring Nobel Laureate to University of Pennsylvania School of Medicine on May 12

May 9, 2011

STOCKHOLM, May 9, 2011 /PRNewswire/ — As part of a global initiative
between Nobel Media AB, the media company of the Nobel Foundation and
AstraZeneca the pharmaceutical company, staff and students at The University
of Pennsylvania
School of Medicine will have the rare opportunity to meet and
learn from a Nobel Prize awarded scientist, Dr Michael Brown, on May 12, 2011.

Awarded the 1985 Nobel Prize in Physiology or Medicine, Dr Brown will
give a lecture at his alma mater, entitled ‘Partnerships, Puzzles and
Paradigms: A collaborative approach to cholesterol’. Dr Brown will explore
the dynamics, challenges and benefits of his partnership with Joseph L.
Goldstein
, fellow recipient of the Nobel Prize, and the ways it contributed
to the pair’s extraordinary success in unraveling many of cholesterol’s
secrets. The lecture is followed by an open question and answer session. In
addition, Dr Brown will host roundtable discussions with graduate and medical
students. On May 13, Dr Brown will give a further lecture to scientists at
AstraZeneca’s research and development facility in Wilmington, Delaware, and
then in front of the same audience, he will discuss the value of
collaboration with Martin Mackay, President of R&D at AstraZeneca.

The event is part of the AstraZeneca Nobel Medicine Initiative, a global
cooperation to bring the inspiring achievements from the Nobel Prize in
Physiology or Medicine to the general public and to AstraZeneca’s leading
research facilities worldwide. The aim of the initiative is to inspire the
scientific community and others through sharing Nobel Prize awarded
achievements and demonstrating how such discoveries are critical to advancing
our understanding of how the human body works. For information about previous
lectures within the initiative, see:

http://nobelprize.org/nobel_organizations/nobelmedia/partnership/s/astraz

eneca/lecture_events/index.html

(Due to the length of these URLs, it may be necessary to copy and paste
the hyperlinks into your Internet browser’s URL address field. Remove the
space if one exists.)

Dr Michael Brown, 1985 Nobel Laureate in Physiology or Medicine,
commented:

“My career with Joe Goldstein is proof that scientific success can come
from long-lasting, creative partnerships. I am greatly looking forward to
meeting students at my alma mater and scientists at AstraZeneca to discuss
the lessons I have learned about partnerships throughout a lifetime in
science.”

Camilla Hylten-Cavallius, CEO of Nobel Media, said:

“We are delighted to continue the lecture series within the AstraZeneca
Nobel Medicine Initiative by bringing students and the scientific community
into close contact with Nobel Laureates.”

Dr. Martin Mackay, President of R&D, AstraZeneca, said:

“AstraZeneca is committed to collaborations with academia, government,
not-for-profits and others in industry to facilitate better, more efficient
drug development for the good of patients. The story of Drs. Brown and
Goldstein is a story of the power of partnership and the extraordinary things
that are possible when people are willing to collaborate. AstraZeneca is
honored to host Dr. Brown to learn from and be inspired by his outstanding
scientific achievements.”

The lectures are one component of a broader program of activity as part
of the AstraZeneca Nobel Medicine Initiative, which also includes online
educational productions and a series of TV documentaries about Physiology or
Medicine. For more information on the initiative, please visit
http://www.astrazeneca.com/Research/news/Article/AstraZeneca-Nobel-Medicine-I
nitiative.

Notes to Editors:

– About Dr Michael Brown

Dr Michael Brown was awarded the Nobel Prize in Physiology or Medicine in
1985 for discoveries concerning the regulation of cholesterol metabolism. For
more information about Dr Brown, please visit:
http://nobelprize.org/nobel_prizes/medicine/laureates/1985/brown.html

– About Nobel Media AB

Nobel Media AB aims to spread knowledge and interest in the Nobel Prize
awarded achievements to a global audience, through digital and broadcast
media, publishing and events. Included in Nobel Media’s portfolio is
Nobelprize.org, the official web site of the Nobel Prize, which received over
41 million visitors during 2010. Production of official television programs
consists of The Nobel Prize Award Ceremonies in Stockholm and Oslo, The Nobel
Banquet, Nobel Documentaries, Nobel Minds, Nobel Laureates and the Nobel
Prize Concert. Through these programs, over 250 million viewers are reached
all over the world.

Copyright (c) Nobel Media AB 2011

Nobel Media(R), Nobel Prize(R), Nobelprize.org(R), Nobel Prize Guide(R)
and Nobel Prize Concert(R) are registered trademarks of the Nobel Foundation.

– About AstraZeneca

AstraZeneca is a global, innovation-driven biopharmaceutical business
with a primary focus on the discovery, development and commercialisation of
prescription medicines for gastrointestinal, cardiovascular, neuroscience,
respiratory and inflammation, oncology and infectious disease. AstraZeneca
operates in over 100 countries and its innovative medicines are used by
millions of patients worldwide. For more information please visit:
http://www.astrazeneca.com


http://nobelprize.org/

SOURCE Nobel Media AB


Source: newswire



comments powered by Disqus